Expression profile of host restriction factors in HIV-1 elite controllers

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · see citing works

Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

Sheehy, A. M., Gaddis, N., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,323 · see citing works

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

Neil, S. J. D., Zang, T. M., & Bieniasz, P. D. (2008) · Nature · doi:10.1038/nature06553 · Cited by 1,886 · see citing works

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,812 · see citing works

The cytoplasmic body component TRIM5α restricts HIV-1 infection in Old World monkeys

Stremlau, M. H., Owens, C. M., Perron, M. J., Kießling, M. K., Autissier, P., & Sodroski, J. (2004) · Nature · doi:10.1038/nature02343 · Cited by 1,810 · see citing works

Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein

Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200 · see citing works

The Interferon-Induced Protein BST-2 Restricts HIV-1 Release and Is Downregulated from the Cell Surface by the Viral Vpu Protein

Damme, N. V., Goff, D. J., Katsura, C., Jorgenson, R. L., Mitchell, R., Johnson, M. C., Stephens, E. B., & Guatelli, J. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.001 · Cited by 1,043 · see citing works

Small self-RNA generated by RNase L amplifies antiviral innate immunity

Malathi, K., Dong, B., Gale, M., & Silverman, R. H. (2007) · Nature · doi:10.1038/nature06042 · Cited by 636 · see citing works

Relationship between T Cell Activation and CD4 + T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of Therapy

Hunt, P. W., Brenchley, J. M., Sinclair, E., McCune, J. M., Roland, M. E., Page, K. A., Hsue, P. Y., Emu, B., Krone, M., Lampiris, H. W., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/524143 · Cited by 634 · see citing works

Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins

Bishop, K. N., Holmes, R. K., Sheehy, A. M., Davidson, N. O., Cho, S., & Malim, M. H. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.057 · Cited by 613 · see citing works

Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome

Yu, Q., König, R., Pillai, S. K., Chiles, K., Kearney, M. F., Palmer, S., Richman, D., Coffin, J. M., & Landau, N. R. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb758 · Cited by 596 · see citing works

Activation of the HIV-1 LTR by T Cell Mitogens and the Trans-Activator Protein of HTLV-I

Siekevitz, M., Josephs, S. F., Dukovich, M., Peffer, N. J., Wong‐Staal, F., & Greene, W. C. (1987) · Science · doi:10.1126/science.2825351 · Cited by 448 · see citing works

Antiretroviral therapy and management of HIV infection

Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 448 · see citing works

Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication

Zheng, Y., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 430 · see citing works

The IFITM Proteins Inhibit HIV-1 Infection

Lu, J., Pan, Q., Rong, L., Liu, S.-L., & Liang, C. (2011) · Journal of Virology · doi:10.1128/jvi.01531-10 · Cited by 417 · see citing works

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11

Li, M., Kao, E., Gao, X., Sandig, H., Limmer, K., Pavon-Eternod, M., Jones, T. E., Landry, S., Pan, T., Weitzman, M. D., et al. (2012) · Nature · doi:10.1038/nature11433 · Cited by 375 · see citing works

Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers

Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H., Parks, R., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 341 · see citing works

APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication

Yu, Q., Chen, D., König, R., Mariani, R., Unutmaz, D., & Landau, N. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408802200 · Cited by 290 · see citing works

Isolation and Characterization of Replication-Competent Human Immunodeficiency Virus Type 1 from a Subset of Elite Suppressors

Blankson, J. N., Bailey, J. R., Thayil, S. M., Yang, H., Lassen, K. G., Lai, J., Gandhi, S. K., Siliciano, J. D., Williams, T. M., & Siliciano, R. F. (2006) · Journal of Virology · doi:10.1128/jvi.02165-06 · Cited by 282 · see citing works

Human TRIM Gene Expression in Response to Interferons

Carthagéna, L., Bergamaschi, A., Luna, J. M., David, A., Uchil, P. D., Margottin-Goguet, F., Mothes, W., Hazan, U., Transy, C., Pancino, G., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004894 · Cited by 279 · see citing works

The Interferon Response Inhibits HIV Particle Production by Induction of TRIM22

Barr, S. D., Smiley, J. R., & Bushman, F. D. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000007 · Cited by 275 · see citing works

Human immunodeficiency virus long terminal repeat responds to T-cell activation signals.

Tong-Starksen, S., Luciw, P. A., & Peterlin, B. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6845 · Cited by 266 · see citing works

TRIM E3 Ligases Interfere with Early and Late Stages of the Retroviral Life Cycle

Uchil, P. D., Quinlan, B. D., Chan, W.-T., Luna, J. M., & Mothes, W. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040016 · Cited by 238 · see citing works

HIV-1 infection of human macrophages directly induces viperin which inhibits viral production

Nasr, N., Maddocks, S., Turville, S. G., Harman, A. N., Woolger, N., Helbig, K. J., Wilkinson, J. C., Bye, C. R., Wright, T. K., Rambukwelle, D., et al. (2012) · Blood · doi:10.1182/blood-2012-01-407395 · Cited by 234 · see citing works

HLA Class I-Restricted T-Cell Responses May Contribute to the Control of Human Immunodeficiency Virus Infection, but Such Responses Are Not Always Necessary for Long-Term Virus Control

Emu, B., Sinclair, E., Hatano, H., Ferre, A. L., Shacklett, B. L., Martin, J. N., McCune, J. M., & Deeks, S. G. (2008) · Journal of Virology · doi:10.1128/jvi.02176-07 · Cited by 222 · see citing works

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

Oxenius, A., Price, D. A., Günthard, H. F., Dawson, S. J., Fagard, C., Perrin, L. H., Fischer, M., Weber, R. K., Plana, M., García, F., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202372199 · Cited by 208 · see citing works

APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells

Berger, G., Durand, S., Fargier, G., Nguyen, X.-N., Cordeil, S., Bouaziz, S., Muriaux, D. M., Darlix, J., & Cimarelli, A. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002221 · Cited by 204 · see citing works

CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21

Chen, H., Li, C., Huang, J., Cung, T. D. H., Seiss, K., Beamon, J., Carrington, M. N., Porter, L. C., Burke, P. S., Yang, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44539 · Cited by 174 · see citing works

Preserved Central Memory and Activated Effector Memory CD4+T-Cell Subsets in Human Immunodeficiency Virus Controllers: an ANRS EP36 Study

Potter, S. J., Lacabaratz, C., Lambotte, O., Pérez-Patrigeón, S., Vingert, B., Sinet, M., Colle, J., Urrutia, A., Scott‐Algara, D., Boufassa, F., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01401-07 · Cited by 172 · see citing works

Genome-Wide mRNA Expression Correlates of Viral Control in CD4+ T-Cells from HIV-1-Infected Individuals

Rotger, M., Dang, K. K., Fellay, J., Heinzen, E. L., Feng, S., Descombes, P., Shianna, K. V., Ge, D., Günthard, H. F., Goldstein, D. B., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000781 · Cited by 169 · see citing works

The Differential Ability of HLA B*5701+Long-Term Nonprogressors and Progressors To Restrict Human Immunodeficiency Virus Replication Is Not Caused by Loss of Recognition of Autologous ViralgagSequences

Migueles, S. A., Laborico, A. C., Imamichi, H., Shupert, W. L., Royce, C., McLaughlin, M. E., Ehler, L. A., Metcalf, J. A., Liu, S., Hallahan, C. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6889-6898.2003 · Cited by 155 · see citing works

Transcription factor FOXO3a controls the persistence of memory CD4+ T cells during HIV infection

van Grevenynghe, J., Procopio, F. A., He, Z., Chomont, N., Riou, C., Zhang, Y., Gimmig, S., Boucher, G., Wilkinson, P. A., Shi, Y., et al. (2008) · Nature Medicine · doi:10.1038/nm1728 · Cited by 153 · see citing works

The Interferon-Induced Gene ISG15 Blocks Retrovirus Release from Cells Late in the Budding Process

Pincetic, A., Kuang, Z., Seo, E. J., & Leis, J. P. (2010) · Journal of Virology · doi:10.1128/jvi.02478-09 · Cited by 149 · see citing works

A whole genome screen for HIV restriction factors

Liu, L., Oliveira, N. M. M., Cheney, K. M., Pade, C., Dreja, H. S., Bergin, A.-M. H., Borgdorff, V., Beach, D., Bishop, C. L., Dittmar, M. T., et al. (2011) · Retrovirology · doi:10.1186/1742-4690-8-94 · Cited by 137 · see citing works

Restriction of HIV-1 replication in macrophages and CD4+ T cells from HIV controllers

Sáez‐Cirión, A., Hamimi, C., Bergamaschi, A., David, A., Versmisse, P., Mélard, A., Boufassa, F., Barré‐Sinoussi, F., Lambotte, O., Rouzioux, C., et al. (2011) · Blood · doi:10.1182/blood-2010-12-327106 · Cited by 126 · see citing works

Primitive hematopoietic cells resist HIV-1 infection via p21Waf1/Cip1/Sdi1

Zhang, J., Scadden, D. T., & Crumpacker, C. S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28971 · Cited by 125 · see citing works

Role of retroviral restriction factors in the interferon-α–mediated suppression of HIV-1 in vivo

Pillai, S. K., Abdel‐Mohsen, M., Guatelli, J., Skasko, M., Monto, A., Fujimoto, K., Yukl, S. A., Greene, W. C., Kovari, H., Rauch, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111573109 · Cited by 118 · see citing works

Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication

Dang, Y., Siew, L. M., Wang, X., Han, Y., Lampen, R. J., & Zheng, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707586200 · Cited by 114 · see citing works

Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity

Furtak, V. A., Mulky, A., Rawlings, S. A., Kozhaya, L., Lee, K., KewalRamani, V. N., & Unutmaz, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009081 · Cited by 111 · see citing works

Infrequent Recovery of HIV from but Robust Exogenous Infection of Activated CD4+T Cells in HIV Elite Controllers

Jülg, B. D., Pereyra, F., Buzón, M. J., Trocha, A. K., Clark, M. J., Baker, B. M., Lian, J., Miura, T., Martínez‐Picado, J., Addo, M. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/653677 · Cited by 110 · see citing works

Human HERC5 restricts an early stage of HIV-1 assembly by a mechanism correlating with the ISGylation of Gag

Woods, M. W., Kelly, J. N., Hattlmann, C. J., Tong, J., Xu, L., Coleman, M. D., Quest, G. R., Smiley, J. R., & Barr, S. D. (2011) · Retrovirology · doi:10.1186/1742-4690-8-95 · Cited by 84 · see citing works

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection

Dyer, W. B., Zaunders, J., Yuan, F., Wang, B., Learmont, J. C., Geczy, A. F., Saksena, N. K., McPhee, D. A., Gorry, P. R., & Sullivan, J. S. (2008) · Retrovirology · doi:10.1186/1742-4690-5-112 · Cited by 84 · see citing works

Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors

Gandhi, S. K., Siliciano, J. D., Bailey, J. R., Siliciano, R. F., & Blankson, J. N. (2007) · Journal of Virology · doi:10.1128/jvi.01533-07 · Cited by 82 · see citing works

Transcriptional Profiling of CD4 T Cells Identifies Distinct Subgroups of HIV-1 Elite Controllers

Vigneault, F., Woods, M. W., Buzón, M. J., Li, C., Pereyra, F., Crosby, S. D., Rychert, J., Church, G. M., Martínez‐Picado, J., Rosenberg, E. S., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01846-10 · Cited by 67 · see citing works

Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease

Zaunders, J., & van Bockel, D. J. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00095 · Cited by 58 · see citing works

Target Cell APOBEC3C Can Induce Limited G-to-A Mutation in HIV-1

Bourara, K., Liegler, T. J., & Grant, R. M. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030153 · Cited by 54 · see citing works

Identification of Molecular Determinants from Moloney Leukemia Virus 10 Homolog (MOV10) Protein for Virion Packaging and Anti-HIV-1 Activity

Abudu, A., Wang, X., Dang, Y., Zhou, T., Xiang, S.-H., & Zheng, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309831 · Cited by 48 · see citing works

How Do HIV Elite Controllers Do What They Do?

Saag, M. S., & Deeks, S. G. (2010) · Clinical Infectious Diseases · doi:10.1086/653678 · Cited by 45 · see citing works

Inhibition of Replication of Reactivated Human Immunodeficiency Virus Type 1 (HIV-1) in Latently Infected U1 Cells Transduced with an HIV-1 Long Terminal Repeat-Driven PKR cDNA Construct

Muto, N. F., Martinand‐Mari, C., Adelson, M. E., & Suhadolnik, R. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9021-9028.1999 · Cited by 44 · see citing works

CD4 + T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors

O’Connell, K. A., Rabi, S. A., Siliciano, R. F., & Blankson, J. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108866108 · Cited by 42 · see citing works

Effects of Cellular Activation on Anti-HIV-1 Restriction Factor Expression Profile in Primary Cells

Raposo, R. A. S., Abdel‐Mohsen, M., Bilska, M., Montefiori, D. C., Nixon, D. F., & Pillai, S. K. (2013) · Journal of Virology · doi:10.1128/jvi.02128-13 · Cited by 39 · see citing works

Silencing p21Waf1/Cip1/Sdi1 expression increases gene transduction efficiency in primitive human hematopoietic cells

Zhang, J., Attar, E. C., Cohen, K. S., Crumpacker, C. S., & Scadden, D. T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302544 · Cited by 36 · see citing works

Unstimulated Primary CD4 + T Cells from HIV-1-Positive Elite Suppressors Are Fully Susceptible to HIV-1 Entry and Productive Infection

Rabi, S. A., O’Connell, K. A., Nikolaeva, D., Bailey, J. R., Jilek, B. L., Shen, L., Page, K. R., Siliciano, R. F., & Blankson, J. N. (2010) · Journal of Virology · doi:10.1128/jvi.01721-10 · Cited by 35 · see citing works

Mutations in the nef and vif genes associated with progression to AIDS in elite controller and slow‐progressor Patients

da Cruz, N. V. G., Amorim, R., Oliveira, F., Speranza, F. A. C., & da Costa, L. J. (2013) · Journal of Medical Virology · doi:10.1002/jmv.23512 · Cited by 24 · see citing works

Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals

Raposo, R. A. S., Abdel‐Mohsen, M., Holditch, S. J., Kuebler, P., Cheng, R. G., Eriksson, E. M., Liao, W. J., Pillai, S. K., & Nixon, D. F. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0313150 · Cited by 16 · see citing works

HIV infection

Deeks, S. G., Overbaugh, J. M., Phillips, A. N., & Buchbinder, S. P. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 657 · see citing works

Human Leukocyte Antigen (HLA) and Immune Regulation: How Do Classical and Non-Classical HLA Alleles Modulate Immune Response to Human Immunodeficiency Virus and Hepatitis C Virus Infections?

Crux, N. B., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00832 · Cited by 243 · see citing works

Innate immunity against HIV-1 infection

Altfeld, M. A., & Gale, M. (2015) · Nature Immunology · doi:10.1038/ni.3157 · Cited by 240 · see citing works

Multiple Origins of Virus Persistence during Natural Control of HIV Infection

Boritz, E., Darko, S. W., Swaszek, L., Wolf, G. S., Wells, D. W., Wu, X., Henry, A. R., Laboune, F., Hu, J., Ambrozak, D. R., et al. (2016) · Cell · doi:10.1016/j.cell.2016.06.039 · Cited by 177 · see citing works

Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

Feng, Y., Baig, T. T., Love, R. P., & Chelico, L. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00450 · Cited by 113 · see citing works

Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth

Kiselinova, M., Spiegelaere, W. D., Buzón, M. J., Malatinková, E., Lichterfeld, M. D., & Vandekerckhove, L. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005472 · Cited by 98 · see citing works

Type I Interferon: Understanding Its Role in HIV Pathogenesis and Therapy

Bosinger, S. E., & Utay, N. S. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0244-6 · Cited by 96 · see citing works

Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress

Murai, J., Zhang, H., Pongor, L. S., Tang, S.-W., Jo, U., Moribe, F., Ma, Y., Tomita, M., & Pommier, Y. G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.117 · Cited by 82 · see citing works

Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells

Puck, A., Aigner, R., Modak, M., Cejka, P., Blaas, D., & Stöckl, J. (2015) · Results in Immunology · doi:10.1016/j.rinim.2015.10.001 · Cited by 80 · see citing works

Novel host restriction factors implicated in HIV-1 replication

Ghimire, D., Rai, M., & Gaur, R. (2018) · Journal of General Virology · doi:10.1099/jgv.0.001026 · Cited by 74 · see citing works

IL-21 induces antiviral microRNA-29 in CD4 T cells to limit HIV-1 infection

Adoro, S., Cubillos‐Ruiz, J. R., Chen, X., Déruaz, M., Vrbanac, V. D., Song, M., Park, S., Murooka, T. T., Dudek, T. E., Luster, A. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms8562 · Cited by 70 · see citing works

The Schlafen family: complex roles in different cell types and virus replication

Liu, F.-R., Zhou, P., Wang, Q., Zhang, M., & Li, D. (2017) · Cell Biology International · doi:10.1002/cbin.10778 · Cited by 69 · see citing works

Role of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication

Jin, D., & Musier-Forsyth, K. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev118.002957 · Cited by 67 · see citing works

A Cell-Intrinsic Inhibitor of HIV-1 Reverse Transcription in CD4+ T Cells from Elite Controllers

Leng, J., Ho, H., Buzón, M. J., Pereyra, F., Walker, B. D., Yu, X. G., Chang, E. J., & Lichterfeld, M. D. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.05.011 · Cited by 61 · see citing works

Select host restriction factors are associated with HIV persistence during antiretroviral therapy

Abdel‐Mohsen, M., Wang, C., Strain, M. C., Lada, S. M., Deng, X., Cockerham, L. R., Pilcher, C. D., Hecht, F. M., Liegler, T. J., Richman, D. D., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000572 · Cited by 52 · see citing works

Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome

Scagnolari, C., & Antonelli, G. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.003 · Cited by 49 · see citing works

HIV-1 functional cure: will the dream come true?

Liu, C., Ma, X., Liu, B., Chen, C., & Zhang, H. (2015) · BMC Medicine · doi:10.1186/s12916-015-0517-y · Cited by 48 · see citing works

ADAR1 and PKR, interferon stimulated genes with clashing effects on HIV-1 replication

Radetskyy, R., Daher, A., & Gatignol, A. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.03.007 · Cited by 44 · see citing works

Antiviral gene expression in psoriasis

Raposo, R. A. S., Gupta, R. A., Abdel‐Mohsen, M., Dimon, M. T., Debbaneh, M. G., Jiang, W. I., York, V. A., Leadabrand, K. S., Brown, G. E., Malakouti, M., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13091 · Cited by 44 · see citing works

Dephosphorylation activates the interferon-stimulated Schlafen family member 11 in the DNA damage response

Malone, D., Lardelli, R. M., Li, M., & David, M. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006588 · Cited by 43 · see citing works

ISG15 expression correlates with HIV-1 viral load and with factors regulating T cell response

Scagnolari, C., Monteleone, K., Selvaggi, C., Pierangeli, A., d’Ettorre, G., Mezzaroma, I., Turriziani, O., Gentile, M., Vullo, V., & Antonelli, G. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.10.007 · Cited by 42 · see citing works

Transcriptomics and Targeted Proteomics Analysis to Gain Insights Into the Immune-control Mechanisms of HIV-1 Infected Elite Controllers

Zhang, W., Ambikan, A. T., Sperk, M., van Domselaar, R., Nowak, P., Noyan, K., Russom, A., Sönnerborg, A. B., & Neogi, U. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.11.031 · Cited by 36 · see citing works

Interferons and beyond: Induction of antiretroviral restriction factors

Hotter, D., & Kirchhoff, F. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0717-307r · Cited by 34 · see citing works

Equine Schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism

Lin, Y.-Z., Sun, L.-K., Zhu, D.-T., Hu, Z., Wang, X.-F., Du, C., Wang, Y.-H., Wang, X.-J., & Zhou, J.-H. (2016) · Virology · doi:10.1016/j.virol.2016.04.024 · Cited by 33 · see citing works

Schlafens Can Put Viruses to Sleep

Kim, E. T., & Weitzman, M. D. (2022) · Viruses · doi:10.3390/v14020442 · Cited by 33 · see citing works

Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo

Abdel‐Mohsen, M., Deng, X., Liegler, T. J., Guatelli, J., Salama, M., Ghanem, H. E.-D. A., Rauch, A., Ledergerber, B., Deeks, S. G., Günthard, H. F., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02687-13 · Cited by 33 · see citing works

Elite control of HIV: is this the right model for a functional cure?

Cockerham, L. R., & Hatano, H. (2014) · Trends in Microbiology · doi:10.1016/j.tim.2014.11.003 · Cited by 32 · see citing works

Schlafens: Emerging Proteins in Cancer Cell Biology

Al‐Marsoummi, S., Vomhof‐DeKrey, E. E., & Basson, M. D. (2021) · Cells · doi:10.3390/cells10092238 · Cited by 32 · see citing works

Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers

de Masson, A., Kirilovsky, A., Zoorob, R., Avettand-Fènoël, V., Morin, V., Oudin, A., Descours, B., Rouzioux, C., & Autran, B. (2014) · AIDS · doi:10.1097/qad.0000000000000295 · Cited by 32 · see citing works

BCL6 represses antiviral resistance in follicular T helper cells

Amet, T., Son, Y. M., Jiang, L., Cheon, I. S., Huang, S., Gupta, S. K., Dent, A. L., Montaner, L. J., Yu, Q., & Sun, J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a1216-513rr · Cited by 26 · see citing works

COMMD1/Murr1 Reinforces HIV-1 Latent Infection through IκB-α Stabilization

Taura, M., Kudo, E., Kariya, R., Goto, H., Matsuda, K., Hattori, S.-I., Vaeteewoottacharn, K., McDonald, F. J., Suico, M. A., Shuto, T., et al. (2014) · Journal of Virology · doi:10.1128/jvi.03105-14 · Cited by 25 · see citing works

Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells

Kobayashi‐Ishihara, M., Smutná, K. F., Alonso, F. E., Argilaguet, J. M., Esteve‐Codina, A., Geiger, K., Genescà, M., Grau-Expósito, J., Duran-Castells, C., Rogenmoser, S., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04841-y · Cited by 25 · see citing works

Host Restriction Factors and Human Immunodeficiency Virus (HIV-1): A Dynamic Interplay Involving All Phases of the Viral Life Cycle

D’Urbano, V., Crignis, E. D., & Re, M. C. (2018) · Current HIV Research · doi:10.2174/1570162x16666180817115830 · Cited by 25 · see citing works

Mechanisms of HIV-1 Control

Soliman, M., Srikrishna, G., & Balagopal, A. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0357-9 · Cited by 24 · see citing works

A compartmentalized type I interferon response in the gut during chronic HIV-1 infection is associated with immunopathogenesis

Dillon, S. M., Guo, K., Austin, G. L., Gianella, S., Engen, P. A., Mutlu, E., Losurdo, J., Swanson, G. R., Chakradeo, P. S., Keshavarzian, A., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001863 · Cited by 23 · see citing works

Hili inhibits HIV replication in activated T cells

Peterlin, B. M., Liu, P., Wang, X., Cary, D., Shao, W., Leoz, M., Hong, T., Pan, T., & Fujinaga, K. (2017) · Journal of Virology · doi:10.1128/jvi.00237-17 · Cited by 21 · see citing works

Structural and biochemical characterization of Schlafen11 N-terminal domain

Hou, P., Hao, W., Qin, B., Li, M., Zhao, R., & Cui, S. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad509 · Cited by 20 · see citing works

Loop 1 of APOBEC3C Regulates its Antiviral Activity against HIV-1

Vasudevan, A. A. J., Balakrishnan, K., Gertzen, C. G. W., Borvető, F., Zhang, Z., Sangwiman, A., Held, U., Küstermann, C., Banerjee, S., Schumann, G. G., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.10.014 · Cited by 19 · see citing works

NK Cells, Monocytes and Macrophages in HIV-1 Control: Impact of Innate Immune Responses

Mensching, L., & Hölzemer, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883728 · Cited by 19 · see citing works

Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation

Leal, F. E., Menezes, S. M., Costa, E. A. S., Brailey, P. M., Gama, L., Segurado, A. A. C., Kallas, E. G., Nixon, D. F., Dierckx, T., Khouri, R., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00985 · Cited by 19 · see citing works

Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1

Vasudevan, A. A. J., Hofmann, H., Willbold, D., Häussinger, D., Koenig, B. W., & Münk, C. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.03.015 · Cited by 17 · see citing works

Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa

Xie, W., Agniel, D. M., Shevchenko, A. K., Malov, S. V., Svitin, A., Cherkasov, N., Baum, M. K., Campa, A. L., Gaseitsiwe, S., Bussmann, H., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0017 · Cited by 16 · see citing works

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

Scheerder, M. D., Hecke, C. V., Zetterberg, H., Fuchs, D., Langhe, N. D., Rutsaert, S., Vrancken, B., Trypsteen, W., Noppe, Y., Gucht, B. V. D., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa003 · Cited by 16 · see citing works

Transposable elements may enhance antiviral resistance in HIV-1 elite controllers

Singh, M., Leddy, S. M., Iñiguez, L., Bendall, M. L., Nixon, D. F., & Feschotte, C. (2025) · Genome biology · doi:10.1186/s13059-025-03484-y · Cited by 15 · see citing works

Dynamic Regulation of Host Restriction Factor Expression over the Course of HIV-1 Infection In Vivo

Raposo, R. A. S., Abdel‐Mohsen, M., Deng, X., Hecht, F. M., Pilcher, C. D., Pillai, S. K., & Nixon, D. F. (2014) · Journal of Virology · doi:10.1128/jvi.01771-14 · Cited by 15 · see citing works

Human Primary Macrophages Derived In Vitro from Circulating Monocytes Comprise Adherent and Non-Adherent Subsets with Differential Expression of Siglec-1 and CD4 and Permissiveness to HIV-1 Infection

Jobe, O., Kim, J., Tycksen, E., Onkar, S., Michael, N. L., Alving, C. R., & Rao, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01352 · Cited by 14 · see citing works

IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis

Raposo, R. A. S., Rougvie, M. D. M., Paquin‐Proulx, D., Brailey, P. M., Cabido, V. D., Zdinak, P. M., Thomas, A. S., Huang, S.-H., Beckerle, G. A., Jones, R. B., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.85811 · Cited by 13 · see citing works

HIV‐1 Infection Dysregulates Cell Cycle Regulatory Protein p21 in CD4+ T Cells Through miR‐20a and miR‐106b Regulation

Guha, D., Mancini, A. E., Sparks, J., & Ayyavoo, V. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25489 · Cited by 13 · see citing works

Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature

Gélinas, J., Gill, D. R., & Hyde, S. C. (2018) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00051-17 · Cited by 13 · see citing works

Gene expression profiling of hematologic malignant cell lines resistant to oncolytic virus treatment

Lee, N. H., Kim, M., Oh, S. Y., Kim, S.-G., Kwon, H.-C., & Hwang, T.-H. (2016) · Oncotarget · doi:10.18632/oncotarget.13598 · Cited by 13 · see citing works

Therapeutic HIV vaccines: Prior setbacks, current advances, and future prospects

Fisher, K., Voronin, Y., & Jefferys, R. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.06.066 · Cited by 12 · see citing works

Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors

Hecke, C. V., Trypsteen, W., Malatinková, E., Spiegelaere, W. D., Vervisch, K., Rutsaert, S., Loes, S. K., Sips, M., & Vandekerckhove, L. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.006 · Cited by 12 · see citing works

Role of MicroRNA Modulation in the Interferon-α/Ribavirin Suppression of HIV-1 In Vivo

Abdel‐Mohsen, M., Deng, X., Danesh, A., Liegler, T. J., Jacobs, E. S., Rauch, A., Ledergerber, B., Norris, P. J., Günthard, H. F., Wong, J. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109220 · Cited by 11 · see citing works

Post-translational modifications inducing proteasomal degradation to counter HIV-1 infection

Proulx, J. M., Borgmann, K., & Park, I.-W. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198142 · Cited by 10 · see citing works

The Multifunction of TRIM26: From Immune Regulation to Oncology

Zou, J., Niu, K., Lü, T., Kan, J., Cheng, H., & Xu, L. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665311516240621114519 · Cited by 9 · see citing works

Short Communication: p21/CDKN1A Expression Shows Broad Interindividual Diversity in a Subset of HIV-1 Elite Controllers

de Pablo, A., Bogoi, R. N., Bejarano, I., Toro, C., Valencia, E., Moreno, V., Martín‐Carbonero, L., Gómez-Hernando, C., & Rodés, B. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0137 · Cited by 9 · see citing works

High Levels of TRIM5α Are Associated with Xenophagy in HIV-1-Infected Long-Term Nonprogressors

Ciccosanti, F., Corazzari, M., Casetti, R., Amendola, A., Collalto, D., Refolo, G., Vergori, A., Taibi, C., D’Offizi, G., Antinori, A., et al. (2021) · Cells · doi:10.3390/cells10051207 · Cited by 9 · see citing works

Strong ifitm1 Expression in CD4 T Cells in HIV Controllers Is Correlated With Immune Activation

Canouï, É., Noël, N., Lécuroux, C., Boufassa, F., Sáez‐Cirión, A., Bourgeois, C., Lambotte, O., & the ANRS CO21 CODEX Study Group (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001166 · Cited by 9 · see citing works

SAMHD1 expression in blood cells of HIV-1 elite suppressors and viraemic progressors

Buchanan, E. L., McAlexander, M. A., & Witwer, K. W. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku428 · Cited by 9 · see citing works

T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV‐1 patients

Bolduan, S., Koppensteiner, H., Businger, R., Rebensburg, S. V., Kunze, C., Brack‐Werner, R., Draenert, R., & Schindler, M. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.1.21865 · Cited by 8 · see citing works

Omic Technologies in HIV: Searching Transcriptional Signatures Involved in Long-Term Non-Progressor and HIV Controller Phenotypes

Tarazona, E. D. L. T., Ayala-Suárez, R., Díez‐Fuertes, F., & Alcamı́, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.926499 · Cited by 8 · see citing works

Interferon-Stimulated Genes that Target Retrovirus Translation

Jäger, N., Pöhlmann, S., Rodnina, M. V., & Ayyub, S. A. (2024) · Viruses · doi:10.3390/v16060933 · Cited by 8 · see citing works

Escherichia coli surface display of single-chain antibody VRC01 against HIV-1 infection

Wang, L.-X., Mellon, M., Bowder, D., Quinn, M., Shea, D. M., Wood, C. A., & Xiang, S.-H. (2014) · Virology · doi:10.1016/j.virol.2014.11.018 · Cited by 8 · see citing works

Increased expression of CDKN1A/p21 in HIV-1 controllers is correlated with upregulation of ZC3H12A/MCPIP1

de Azevedo, S. S. D., Alves, M. R., Côrtes, F. H., Delatorre, E. O., Spangenberg, L., Naya, H., Seito, L. N., Hoagland, B., Grinsztejn, B. G. J., Veloso, V. G., et al. (2020) · Retrovirology · doi:10.1186/s12977-020-00522-4 · Cited by 8 · see citing works

SAMHD1 transcript upregulation during SIV infection of the central nervous system does not associate with reduced viral load

Buchanan, E. L., Espinoza, D. A., McAlexander, M. A., Myers, S. L., Moyer, A. L., & Witwer, K. W. (2016) · Scientific Reports · doi:10.1038/srep22629 · Cited by 7 · see citing works

Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression

Valenzuela-Fernández, A., Cabrera-Rodríguez, R., Casado, C., Pérez-Yanes, S., Pernas, M., García-Luis, J., Marfil, S., Olivares, I., Estévez‐Herrera, J., Trujillo‐González, R., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092172 · Cited by 7 · see citing works

Immune escape mutations in HIV-1 controllers in the Brazilian Amazon region

Gomes, S. T. M., Amoras, E. D. S. G., Gomes, É. R., Queiroz, M. A. F., Sousa, E. C., Massafra, J. M. D. V., Lemos, P. D. S., Júnior, J. L. D. S. G. V., Ishak, R., & Vallinoto, A. C. R. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05268-0 · Cited by 6 · see citing works

The innate immune factor RPRD2/REAF and its role in the Lv2 restriction of HIV

Jackson-Jones, K. A., McKnight, Á., & Sloan, R. D. (2023) · mBio · doi:10.1128/mbio.02572-21 · Cited by 6 · see citing works

Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivo

Katsounas, A. (2015) · Journal of AIDS & Clinical Research · doi:10.4172/2155-6113.1000410 · Cited by 6 · see citing works

HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice

Petit, N. Y., Lambert-Niclot, S., Marcelin, A., Garcia, S., & Marodon, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138420 · Cited by 6 · see citing works

TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size

Ghneim, K., ten-Caten, F., Santana, A. C., Latif, M. B., Díaz-Dinamarca, D. A., García‐Salum, T., Estrada, P. M. D. R., Sohal, P., Strongin, Z., Harper, J. L., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02458-x · Cited by 5 · see citing works

Antigen specificities of HIV-infected cells: A role in infection and persistence?

Faua, C., Fafi‐Kremer, S., & Gantner, P. (2023) · Journal of Virus Eradication · doi:10.1016/j.jve.2023.100329 · Cited by 5 · see citing works

Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy

Bachtel, N. D., Beckerle, G. A., Mota, T. M., Rougvie, M. D. M., Raposo, R. A. S., Jones, R. B., Nixon, D. F., & Apps, R. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0162 · Cited by 5 · see citing works

Inhibition of caspase pathways limits CD4+ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissue

Holloway, A. J., Saito, T. B., Naqvi, K. F., Huante, M. B., Fan, X., Lisinicchia, J. G., Gelman, B. B., Endsley, J. J., & Endsley, M. A. (2024) · Retrovirology · doi:10.1186/s12977-024-00641-2 · Cited by 4 · see citing works

Persistent viral control status is associated with enhanced innate immune responses in people with HIV-1

dos Santos, J. C., Groenendijk, A. L., Ruijten, S. D. E., Knoll, R., Vadaq, N., ter Horst, R., Fok, E. T., Witkowski, W., Blaauw, M. J. T., van Eekeren, L. E., et al. (2026) · iScience · doi:10.1016/j.isci.2026.114807 · Cited by 4 · see citing works

Relative mRNA Expression Levels of Restriction Factors and Antiviral Genes in Fetal and Adult Human Monocytes and Monocyte-Derived Macrophages

Trang, K., Raposo, R. A. S., Lowe, M. M., Krow‐Lucal, E., Yonemoto, W. M., Cabido, V. D., SenGupta, D., & McCune, J. M. (2017) · Viral Immunology · doi:10.1089/vim.2016.0160 · Cited by 4 · see citing works

Learning from nature: HIV elite controllers as blueprints for a functional cure

Kalidasan, V., & Das, K. T. (2025) · Virology Journal · doi:10.1186/s12985-025-03042-9 · Cited by 3 · see citing works

Overview of Structural and Functional Insights of SLFN12 Associated With Different Diseases

Tilmisani, M., Alhazmi, S., Alnajashi, H. A., & Alyoubi, R. A. (2024) · Cureus · doi:10.7759/cureus.59515 · Cited by 3 · see citing works

Restriction of HIV-1 infection in sickle cell trait

Kumari, N., Nouraie, M. S., Ahmad, A., Lassiter, H., Khan, J. I., Diaz, S. F., Afangbedji, N. K. A., Wang, S., Houston, P. E., Ammosova, T., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004247 · Cited by 3 · see citing works

Evolutionary Distance of Amino Acid Sequence Orthologs across Macaque Subspecies: Identifying Candidate Genes for SIV Resistance in Chinese Rhesus Macaques

Ross, C. T., Roodgar, M., & Smith, D. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123624 · Cited by 3 · see citing works

CCR5∆32 and SDF1 3′A: Gene Variants, Expression and Influence on Biological Markers for the Clinical Progression to AIDS among HIV-1 Virus Controllers in a Mixed Population of the Amazon Region of Brazil

Lima, É. R. G., Queiroz, M. A. F., Lima, S. S., Machado, L. F. A., Vallinoto, I. M. V. C., Vallinoto, A. C. R., Figueiredo, F. A. D. P. L., Guerreiro, J. F., Ishak, M. D. O. G., & Ishak, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054958 · Cited by 2 · see citing works

Role of APOBEC3H in the Viral Control of HIV Elite Controller Patients

Benito, J. M., Hillung, J., Restrepo, C., Cuevas, J. M., León, A., Ruíz-Mateos, E., Muñoz, R. P., Górgolas, M., Sanjuán, R., & Rallón, N. I. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.22317 · Cited by 2 · see citing works

miRNAs and SAMHD1 regulation in vitro and in a model of HIV CNS disease

Witwer, K. W., Buchanan, E. L., Myers, S. L., & McAlexander, M. A. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0380-y · Cited by 2 · see citing works

Schlafen 5 is an intracellular immune checkpoint and controls IFN responses in pancreatic ductal adenocarcinoma

Fischietti, M., Ζαννίκου, Μ., Beauchamp, E. M., Saleiro, D., Baran, A. H., Hryhorysak, B., Magaña, J. N. G., Fajardo, E. L., Blyth, G. T., Castro, B. A., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.190031 · Cited by 1 · see citing works

HIV controlador de elite: relato de caso

Pinheiro, I. V., Poliseli, H. C., Costa, G. M., Carneiro, R. A. V., & Kassuya, C. A. L. (2022) · Research Society and Development · doi:10.33448/rsd-v11i10.33057 · Cited by 1 · see citing works

Control of HIV-1C Replication Both in Vivo and in Vitro

Xie, W. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

One Step Closer to HIV Eradication?

Autran, B., Hamimi, C., & Katlama, C. (2014) · Current treatment options in infectious diseases/Current treatment options in infectious disease · doi:10.1007/s40506-014-0017-1

One Step Closer to HIV

Hamimi, C., & Katlama, C. (2014)

Characterizing The Role Of The Cellular Protein Schlafen 11 In Flavivirus Replication

Valdez, F. (2018) · DigitalCommons@UTEP (The University of Texas at El Paso)

Increased expression of MCPIP1 in HIV-1 controllers is correlated with overexpression of p21Preprint

de Azevedo, S. S. D., Alves, M. R., Côrtes, F. H., Delatorre, E. O., Hoagland, B., Grinsztejn, B. G. J., Veloso, V. G., Morgado, M. G., Souza, T. M. L., & Bello, G. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/611871

IMMUNE RESPONSES IMPORTANT IN THE REGULATION OF HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1) AND HEPATITIS C VIRUS (HCV) IN PEOPLE WHO INJECT DRUGS (PWID)

Soliman, M. (2020)

Epigenetic and Post-Translational Regulation of Schlafen Family Expression and Their Differential Methods of Regulating Proteins

Rajpathy, O., & Vomhof‐DeKrey, E. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211058

Additional file 1 of Inhibition of caspase pathways limits CD4+ T cell loss and restores host anti-retroviral function in HIV-1 infected humanized mice with augmented lymphoid tissue

Holloway, A. J., Saito, T. B., Naqvi, K. F., Huante, M. B., Fan, X., Lisinicchia, J. G., Gelman, B. B., Endsley, J. J., & Endsley, M. A. (2024) · Figshare · doi:10.6084/m9.figshare.25734542

Caractérisation et conservation des mécanismes antiviraux des protéines IFITMs

Appourchaux, R. (2017) · theses.fr (ABES) · doi:10.70675/d001d208z7f71z40f3za8abzbf3a6cd40964

Efficacité et évolution de la réponse lymphocytaire T CD8 au cours de l'infection par VIH-1

White, E. (2022) · theses.fr (ABES) · doi:10.70675/46537244ze125z43e1z9c39z92cf9f645f78

Évolution des préférences d'usage de codons et manipulation de la fidelité de la traduction

Borvető, F. (2021) · theses.fr (ABES) · doi:10.70675/8c3497aazfaf6z45cfz8cfazd5bc634cfd17

Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral Therapy

Bachtel, N. D., Beckerle, G. A., Mota, T. M., Rougvie, M. D. M., Raposo, R. A. S., Jones, R. B., Nixon, D. F., & Apps, R. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2018.0162 · Cited by 5 · see citing works

Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication In Vitro and Modulate HIV Restriction Factor Expression

Jacobs, E. S., Keating, S. M., Abdel‐Mohsen, M., Gibb, S. L., Heitman, J. W., Inglis, H. C., Martin, J. N., Zhang, J., Kaidarova, Z., Deng, X., et al. (2017) · Journal of Virology · doi:10.1128/jvi.02051-16 · Cited by 48 · see citing works

Dynamic Regulation of Host Restriction Factor Expression over the Course of HIV-1 Infection In Vivo

Raposo, R. A. S., Abdel‐Mohsen, M., Deng, X., Hecht, F. M., Pilcher, C. D., Pillai, S. K., & Nixon, D. F. (2014) · Journal of Virology · doi:10.1128/jvi.01771-14 · Cited by 15 · see citing works

Early treated HIV-1 positive individuals demonstrate similar restriction factor expression profile as long-term non-progressors

Hecke, C. V., Trypsteen, W., Malatinková, E., Spiegelaere, W. D., Vervisch, K., Rutsaert, S., Loes, S. K., Sips, M., & Vandekerckhove, L. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.006 · Cited by 12 · see citing works

CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21

Chen, H., Li, C., Huang, J., Cung, T. D. H., Seiss, K., Beamon, J., Carrington, M. N., Porter, L. C., Burke, P. S., Yang, Y., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44539 · Cited by 174 · see citing works